AUSTINPX LIVE EVENT SERIES
Join us for AustinPx LIVE, our online event series designed to give you a closer look at who we are and what we do.
Upcoming Live Events
Straight from the Source: A Live Q&A with the Inventors of KinetiSol™
Tuesday, May 19th @ 11am CT / 12pm EDT
In this special 30-minute session, join KinetiSol experts Chris Brough (Chief Technical Officer), Dave Miller (Chief Scientific Officer), and Justin Keen (Senior Vice President of Operations) for a live roundtable and open Q&A. This conversation is entirely audience driven, giving attendees the opportunity to ask whatever they would like about the technology, from formulation strategy and process fundamentals to scale-up, manufacturability, and real-world program experience. The discussion will draw on the team’s combined scientific, technical, and operational expertise behind the development and commercialization of KinetiSol. Bring your questions and hear directly from the experts who helped create the technology.
Previous Events
Re-Thinking ASD Development: Designing for Scale from Day One
Wednesday, March 18th @ 11am CT / 12pm EDT
Chief Technology Officer, Chris Brough, Ph.D., will lead a discussion on what it takes to successfully scale amorphous solid dispersions from early development into manufacturing. He will explore common scale-up challenges across ASD technologies, the data and decisions that matter most as programs move toward GMP, and how early formulation and process choices can either enable or complicate downstream execution. KinetiSol™ Technology will be highlighted as part of AustinPx’s broader ASD capabilities, with perspective on how its operating principles, particle characteristics, and rapid prototyping approach can simplify scale-up for the right molecules. This 30-minute session includes a 25-minute presentation followed by live Q&A.
Re-thinking ASD Development: When Your Molecule Breaks the Rules
Thursday, January 22nd @ 11am CT / 12pm EDT
Chief Scientific Officer, Dave Miller, Ph.D., will explore how KinetiSol™ is reshaping the design space for amorphous solid dispersions (ASDs). He’ll break down how our solvent-free platform enables rapid screening, broader excipient use, and higher-performing formulations compared to conventional technologies like spray drying or HME. The session will also address scalability, process efficiency, and why more teams are turning to KinetiSol earlier in development. This 30-minute session includes a 25-minute presentation followed by live Q&A.
From Brick Dust to Breakthrough: The Power of Enabled Formulation
Wednesday, October 22nd @ 11am CT / 12pm EDT
Chief Scientific Officer, Dave Miller, Ph.D., will share how AustinPx uses enabling formulation strategies to advance molecules once considered too complex to develop. He’ll highlight how our expertise with KinetiSol™, polymer and excipient screening, and biopharm-guided design-of-experiments creates formulations that achieve exposure, maintain stability, and are built for real-world manufacturability. This 30-minute session includes a 20-minute presentation followed by live Q&A.
From Molecule to Milestone: Fast-Track Formulation
Thursday, September 25th 11am CT / 12pm EDT
Join us for the third session in our AustinPx Live series! Chief Scientific Officer, Dave Miller, Ph.D., will share how AustinPx approaches conventional formulation to accelerate First-in-Human studies without sacrificing scientific rigor. He’ll highlight how our expertise in powder-in-capsule dosing, phase-appropriate analytical support, and early manufacturability considerations helps sponsors navigate tight timelines and reach the clinic with confidence. This 30-minute session includes a 20-minute presentation followed by live Q&A.
Navigating Complexity: Tailored Analytical & Preclinical Services
Tuesday, August 19th | 11am-11:30am CT
In the second episode of AustinPx Live, Chief Scientific Officer, Dave Miller, Ph.D., will share how AustinPx designs data-driven, early-phase strategies to solve complex drug development challenges. He’ll highlight our tailored analytical services, preclinical expertise, and how they connect with our broader CDMO model. This 30-minute session includes a 20-minute presentation followed by Q&A.
Inside AustinPx: Live Company Overview
Wednesday, July 9th | 11am-11:30am CT
We kicked off our new AustinPx Live series with an inside look at our capabilities. AustinPx's Chief Scientific Officer, Dave Miller, Ph.D., walked through who we are, what we do, and how our integrated CDMO services and KinetiSol technology are helping partners overcome complex drug development challenges.